These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31792645)

  • 21. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy.
    Turner E; Jones M; Vaz LR; Coleman T
    Nicotine Tob Res; 2019 Jul; 21(8):1001-1010. PubMed ID: 29579233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
    Roberts E; Eden Evins A; McNeill A; Robson D
    Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy.
    Cather C; Hoeppner S; Pachas G; Pratt S; Achtyes E; Cieslak KM; Evins AE
    J Dual Diagn; 2017; 13(3):168-178. PubMed ID: 28414583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Varenicline on Alcohol Consumption in Subjects With Alcohol Use Disorders: Systematic Review and Meta-Analyses.
    Gandhi KD; Mansukhani MP; Karpyak VM; Schneekloth TD; Wang Z; Kolla BP
    J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32097546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.
    Mercié P; Arsandaux J; Katlama C; Ferret S; Beuscart A; Spadone C; Duvivier C; Reynes J; Wirth N; Moinot L; Bénard A; Zucman D; Duval X; Molina JM; Spire B; Fagard C; Chêne G;
    Lancet HIV; 2018 Mar; 5(3):e126-e135. PubMed ID: 29329763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials.
    Kishi T; Matsunaga S; Oya K; Ikuta T; Iwata N
    Int J Neuropsychopharmacol; 2015 Jun; 18(12):. PubMed ID: 26091818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia.
    Liu ME; Tsai SJ; Jeang SY; Peng SL; Wu SL; Chen MC; Tsai YL; Yang ST
    Psychiatry Res; 2011 Nov; 190(1):79-84. PubMed ID: 21636135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia.
    Santos B; González-Fraile E; Zabala A; Guillén V; Rueda JR; Ballesteros J
    J Psychopharmacol; 2018 Nov; 32(11):1155-1166. PubMed ID: 30324844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials.
    Chang CH; Lane HY; Tseng PT; Chen SJ; Liu CY; Lin CH
    J Psychopharmacol; 2019 Apr; 33(4):436-448. PubMed ID: 30730250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
    Cerimele JM; Durango A
    J Clin Psychiatry; 2012 Aug; 73(8):e1039-47. PubMed ID: 22967780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
    Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL
    J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginkgo biloba for cognitive impairment and dementia.
    Birks J; Grimley EV; Van Dongen M
    Cochrane Database Syst Rev; 2002; (4):CD003120. PubMed ID: 12519586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
    Zhong Z; Zhao S; Zhao Y; Xia S
    Compr Psychiatry; 2019 Nov; 95():152125. PubMed ID: 31669972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Sterling LH; Windle SB; Filion KB; Touma L; Eisenberg MJ
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26903004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.
    Jones C
    J Clin Psychopharmacol; 2018 Jun; 38(3):247-249. PubMed ID: 29505470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis.
    McKee SA; Smith PH; Kaufman M; Mazure CM; Weinberger AH
    Nicotine Tob Res; 2016 May; 18(5):1002-11. PubMed ID: 26446070
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.